NKG2D及其配体治疗胃癌的研究进展  

Research progress of NKG2D and its ligands in treatment of gastric cancer

在线阅读下载全文

作  者:李宗睿 刘为朋 胡宝光[1] Li Zongrui;Liu Weipeng;Hu Baoguang(Department of Gastrointestinal Surgery,Binzhou Medical University Hospital,Binzhou 256600,China)

机构地区:[1]滨州医学院附属医院胃肠外科,滨州256600

出  处:《国际医药卫生导报》2023年第20期2852-2856,共5页International Medicine and Health Guidance News

基  金:山东省自然科学基金(ZR2017LHO50)。

摘  要:自然杀伤细胞2D(natural killer cell 2D,NKG2D)及其配体在NK细胞识别、启动、增强或抑制淋巴细胞效应功能上发挥着重要作用。近年来,随着肿瘤免疫逃避研究的深入,NK细胞上的NKG2D受体成为一个研究热门。胃癌作为严重影响人类寿命的疾病,其治疗一直是难以突破的难题。近年来,针对癌症的免疫治疗取得了重大突破。NKG2D及其配体可能是一个潜在的免疫治疗方向,故本文综述了NKG2D及其配体治疗胃癌的研究进展。Natural killer cell 2D(NKG2D)and its ligands play an important role in the recognition,initiation,enhancement,or inhibition of lymphocyte effects in NK cells.In recent years,the NKG2D receptor on NK cells has become a hot research topic with the deepening of tumor immune evasion research.As a serious disease affecting human life span,gastric cancer's treatment has been a difficult problem.In recent years,major breakthroughs have been made in the immunotherapy of cancer.NKG2D and its ligands may be a potential direction of immunotherapy.Therefore,this paper reviews the research progress of NKG2D and its ligands in the treatment of gastric cancer.

关 键 词:胃癌 NK细胞 肿瘤免疫 免疫逃避 NKG2D 进展 

分 类 号:R735.2[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象